GlaxoSmithKline has begun clinical testing for a new vaccine that will be available next year.
GlaxoSmithKline, a British pharmaceutical corporation, has begun phase three trials of a new Covid-19 vaccine developed in collaboration with SK Bioscience, a South Korean business.
They announced yesterday that they would compare their vaccine to the Oxford/AstraZeneca version in a global research involving 4,000 participants.
They want to get it through the World Health Organization’s Covax program, which aims to make vaccines more widely available in low-income nations. If the trials go well and authorities approve, it might be ready in the first half of 2022.
“There remains a need for accessible and inexpensive Covid-19 vaccinations to safeguard people around the world,” said Thomas Breuer, GSK’s chief global health officer.
Yesterday, 32,181 instances were registered across the UK, with 50 deaths occurring within 28 days after a positive test.
Meanwhile, an expert has asked for booster doses to be given to the over-80s and other vulnerable groups in the UK as soon as possible.
Professor Paul Hunter of the University of East Anglia believes that a larger campaign is unnecessary because vaccines are still helpful in preventing catastrophic disease.
However, he stated that those who did not respond well to the first dosages would require boosters soon.
“Individuals with severe underlying disease, people with severe cancers on chemotherapy, people on high-dose steroids for autoimmune disorders, people who have had solid organ transplants, people who are morbidly obese” are among those who fall into this category, according to him.
“I would also include the over-80s in that group.”
“These people won’t have responded well to vaccine,” Prof Hunter noted.
“They need to be boosted, and they need to be boosted soon.” His remarks came as the Joint Committee on Vaccination and Immunization (JCVI) was getting ready to make a final judgment on the booster campaign.
Prof Hunter predicted that the UK was on the verge of attaining “epidemic equilibrium,” which would mean an average of 45,000 infections per day.
He predicted that the majority of patients would eventually be asymptomatic, adding, “After a few years, we won’t see Covid “the disease” any longer.” In most cases, pandemics endure roughly three years. The last major coronavirus pandemic, which occurred in 1890 with the Russian flu, lasted three years.
“The virus that caused the Russian flu is still with us, and it’s probably not all that different from the virus that spread 130 years ago, but we don’t notice it.”Brinkwire Summary News”.